SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | CATALYST PHARMACEUTICALS, INC. | 7,120,417 | 6.7% | EDGAR |
SC 13G/A | 2024-02-12 | Flynn James E | CATALYST PHARMACEUTICALS, INC. | 8,888,901 | 8.3% | EDGAR |
SC 13G/A | 2024-01-25 | STATE STREET CORP | CATALYST PHARMACEUTICALS, INC. | - | 6.4% | EDGAR |
SC 13G/A | 2024-01-22 | BlackRock Inc. | CATALYST PHARMACEUTICALS, INC. | 15,821,401 | 14.8% | EDGAR |
SC 13G/A | 2023-02-14 | ARMISTICE CAPITAL, LLC | CATALYST PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-10 | Flynn James E | CATALYST PHARMACEUTICALS, INC. | 5,884,448 | 5.6% | EDGAR |
SC 13G | 2023-02-09 | VANGUARD GROUP INC | CATALYST PHARMACEUTICALS, INC. | 6,768,741 | 6.5% | EDGAR |
SC 13G/A | 2023-02-08 | STATE STREET CORP | CATALYST PHARMACEUTICALS, INC. | - | 7.6% | EDGAR |
SC 13G/A | 2023-01-26 | BlackRock Inc. | CATALYST PHARMACEUTICALS, INC. | 15,690,326 | 15.1% | EDGAR |
SC 13G/A | 2023-01-20 | BlackRock Inc. | CATALYST PHARMACEUTICALS, INC. | 15,690,326 | 15.1% | EDGAR |
SC 13G | 2022-11-14 | Flynn James E | CATALYST PHARMACEUTICALS, INC. | 6,060,491 | 5.8% | EDGAR |
SC 13G/A | 2022-10-07 | BlackRock Inc. | CATALYST PHARMACEUTICALS, INC. | 15,268,931 | 14.9% | EDGAR |
SC 13G/A | 2022-02-15 | ARMISTICE CAPITAL, LLC | CATALYST PHARMACEUTICALS, INC. | 9,572,000 | 9.3% | EDGAR |
SC 13G/A | 2022-02-09 | STATE STREET CORP | CATALYST PHARMACEUTICALS, INC. | - | 4.9% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | CATALYST PHARMACEUTICALS, INC. | 4,836,313 | 4.7% | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | CATALYST PHARMACEUTICALS, INC. | 7,684,698 | 7.5% | EDGAR |
SC 13G/A | 2021-02-16 | ARMISTICE CAPITAL, LLC | CATALYST PHARMACEUTICALS, INC. | 10,000,000 | 9.7% | EDGAR |
SC 13G | 2021-02-10 | VANGUARD GROUP INC | CATALYST PHARMACEUTICALS, INC. | 5,771,079 | 5.6% | EDGAR |
SC 13G | 2021-02-05 | STATE STREET CORP | CATALYST PHARMACEUTICALS, INC. | - | 5.9% | EDGAR |
SC 13G/A | 2021-01-29 | BlackRock Inc. | CATALYST PHARMACEUTICALS, INC. | 7,744,197 | 7.5% | EDGAR |